Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
03 Settembre 2024 - 10:30PM
Business Wire
Charles River Laboratories International, Inc. (NYSE: CRL)
announced today that it will present at two upcoming investor
conferences, including:
- Morgan Stanley 22nd Annual Global Healthcare Conference on
Thursday, September 5th, at 9:15 a.m. EDT; and
- Baird 2024 Global Healthcare Conference on Tuesday, September
10th, at 10:15 a.m. EDT.
Management will present an overview of Charles River’s strategic
focus, business developments, and recent trends.
A live webcast of each presentation will be available through a
link that will be posted on the Investor Relations section of the
Charles River website at ir.criver.com. A webcast replay will be
accessible through the same website after each presentation and
will remain available for at least two weeks.
About Charles River
Charles River provides essential products and services to help
pharmaceutical and biotechnology companies, government agencies and
leading academic institutions around the globe accelerate their
research and drug development efforts. Our dedicated employees are
focused on providing clients with exactly what they need to improve
and expedite the discovery, early-stage development and safe
manufacture of new therapies for the patients who need them. To
learn more about our unique portfolio and breadth of services,
visit www.criver.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240903345318/en/
Investor Relations Contact: Todd Spencer Corporate Vice
President, Investor Relations 781.222.6455 todd.spencer@crl.com
Grafico Azioni Charles River Laboratories (NYSE:CRL)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Charles River Laboratories (NYSE:CRL)
Storico
Da Dic 2023 a Dic 2024
